Morgan Stanley’s Werewolf Therapeutics HOWL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.6K | Sell |
27,200
-80,627
| -75% | -$87.9K | ﹤0.01% | 6517 |
|
|
2025
Q1 | $105K | Sell |
107,827
-30,315
| -22% | -$29.5K | ﹤0.01% | 5988 |
|
|
2024
Q4 | $204K | Buy |
138,142
+19,102
| +16% | +$28.3K | ﹤0.01% | 5776 |
|
|
2024
Q3 | $252K | Buy |
119,040
+70,028
| +143% | +$148K | ﹤0.01% | 5663 |
|
|
2024
Q2 | $120K | Buy |
49,012
+28,433
| +138% | +$69.4K | ﹤0.01% | 5901 |
|
|
2024
Q1 | $133K | Buy |
20,579
+19,379
| +1,615% | +$126K | ﹤0.01% | 5876 |
|
|
2023
Q4 | $4.63K | Sell |
1,200
-1,300
| -52% | -$5.02K | ﹤0.01% | 7019 |
|
|
2023
Q3 | $5.35K | Hold |
2,500
| – | – | ﹤0.01% | 6901 |
|
|
2023
Q2 | $7.63K | Hold |
2,500
| – | – | ﹤0.01% | 6897 |
|
|
2023
Q1 | $6.5K | Sell |
2,500
-12
| -0.5% | -$31 | ﹤0.01% | 7000 |
|
|
2022
Q4 | $5.15K | Sell |
2,512
-7,975
| -76% | -$16.4K | ﹤0.01% | 7138 |
|
|
2022
Q3 | $47K | Sell |
10,487
-11,799
| -53% | -$52.9K | ﹤0.01% | 6436 |
|
|
2022
Q2 | $91K | Buy |
22,286
+14,656
| +192% | +$59.8K | ﹤0.01% | 6324 |
|
|
2022
Q1 | $33K | Sell |
7,630
-433
| -5% | -$1.87K | ﹤0.01% | 6899 |
|
|
2021
Q4 | $96K | Buy |
8,063
+6,549
| +433% | +$78K | ﹤0.01% | 6466 |
|
|
2021
Q3 | $26K | Buy |
1,514
+1,247
| +467% | +$21.4K | ﹤0.01% | 6992 |
|
|
2021
Q2 | $5K | Buy |
+267
| New | +$5K | ﹤0.01% | 7378 |
|